Literature DB >> 7505689

Direct sequencing of the complete CFTR gene: the molecular characterisation of 99.5% of CF chromosomes in Wales.

J P Cheadle1, M C Goodchild, A L Meredith.   

Abstract

We have performed an extensive mutation analysis on 184 CF families in Wales. In our previous study, mutations on 329/369 CF chromosomes were identified after screening for delta F508 and sixteen other mutations. To identify the mutations on the remaining 40 uncharacterized CF chromosomes, we have carried out direct DNA sequencing over the complete coding region, intron splice sites, and part of the promoter region of the CFTR gene. During this study we have designed a set of internal sequencing primers which allow clear sequencing through the aforementioned regions. Sequence analysis revealed 15 further mutations (4 of which are novel), and 10 previously described polymorphisms. In total, we have identified 29 mutations, the distribution of which provides further insight into the functional domains of the CFTR protein. We have characterised 99.5% of the CF chromosomes (365/367, one sample degraded). In order to ascertain accurate frequency data for the Welsh population, CF families with at least 3 'Welsh' grandparents were strictly regarded as 'Welsh'. Of these 91 families, delta F508 accounts for 71.6%, 621 + 1G-->T 6.6% and 1898 + 1G-->A 5.5%. The implications for CF population screening in Wales are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505689     DOI: 10.1093/hmg/2.10.1551

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  6 in total

1.  Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations.

Authors:  A Bonizzato; L Bisceglia; C Marigo; E Nicolis; C Bombieri; C Castellani; G Borgo; L Zelante; G Mastella; G Cabrini
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

2.  Search for mutations in pancreatic sufficient cystic fibrosis Italian patients: detection of 90% of molecular defects and identification of three novel mutations.

Authors:  V Brancolini; L Cremonesi; E Belloni; E Pappalardo; R Bordoni; M Seia; S Russo; R Padoan; A Giunta; M Ferrari
Journal:  Hum Genet       Date:  1995-09       Impact factor: 4.132

3.  Detection of more than 50 different CFTR mutations in a large group of German cystic fibrosis patients.

Authors:  T Dörk; F Mekus; K Schmidt; J Bosshammer; R Fislage; T Heuer; V Dziadek; T Neumann; N Kälin; U Wulbrand
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

4.  A cluster of cystic fibrosis mutations in exon 17b of the CFTR gene: a site for rare mutations.

Authors:  B Mercier; W Lissens; G Novelli; L Kalaydjieva; M de Arce; N Kapranov; N Canki Klain; X Estivill; A Palacio; S Cashman
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

5.  Genotype patterns for mutations of the cystic fibrosis transmembrane conductance regulator gene: a retrospective descriptive study from Saudi Arabia.

Authors:  Hanaa Hasan Banjar; Lin Tuleimat; Abdul Aziz Agha El Seoudi; Ibrahim Mogarri; Sami Alhaider; Imran Yaqoob Nizami; Talal AlMaghamsi; Sara Andulrahman Alkaf; Nabil Moghrabi
Journal:  Ann Saudi Med       Date:  2020-02-06       Impact factor: 1.526

6.  BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.

Authors:  J M Lancaster; M E Carney; J Gray; J Myring; C Gumbs; J Sampson; D Wheeler; E France; R Wiseman; P Harper; P A Futreal
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.